[The macula in Adamantiades-Behçet disease].
Adamantiades-Behçet disease is a well known clinical entity in the Mediterranean area. Signs and complications in these patients, arising from the macular area, are often overlooked for a prolonged period of time, because they are masked by the inflammatory signs of the anterior segment and/or the vitreous. Although blindness, in most cases, is the result of the optic disc atrophy, the macular alterations--as a sequelae of inflammation--are responsible for the low visual acuity. The authors in a retrospective clinical study of the last 100 consecutive cases of A-B disease, studied these macular alterations in detail. Their findings are also described in detail. Therapeutic modalities center around treatment with steroids, Cyclosporine A, and argon laser application. The results obtained from a long follow-up period are discussed.
Palimeris
G
G
Clinique Ophtalmologique Universitaire d'Athènes, Grèce.
Theodossiades
G
G
Constantinidou
B
B
Chimonidou
E
E
D001528:Behcet Syndrome / Q000150:complications* / Q000188:drug therapy / Q000601:surgery; D003524:Cyclosporins / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D053685:Laser Therapy; D008266:Macula Lutea / Q000473:pathology / Q000503:physiopathology*; D008297:Male; D012164:Retinal Diseases / Q000188:drug therapy / Q000209:etiology* / Q000601:surgery; D013256:Steroids / Q000627:therapeutic use
D003524:Cyclosporins; D007166:Immunosuppressive Agents; D013256:Steroids
La macula dans le syndrome d'Adamantiades-Behçet.